院前急诊麻醉后重型创伤性脑损伤的呼气末与动脉二氧化碳分压差:一项回顾性观察研究
英国东部院前重症团队2015年4月1日至2017年12月31日期间对接受院前急诊麻醉(PHEA)的成人重型TBI患者进行回顾性队列研究,最终40例有完整配对数据纳入分析。到达医院时ETCO2-PaCO2差平均1.7(±1.0)kPa(12.8 mm Hg),相关性中等(R2=0.23,p=0.002);Bland-Altman偏倚1.7(95%CI 1.4~2.0)kPa,一致性界限上限3.6(95%CI 3.0~4.1)kPa、下限-0.2(95%CI -0.8~0.3)kPa。合并严重胸部创伤者差值更大,为2.0(±1.1)kPa(15.1 mm Hg),p=0.01,且该亚组无显著相关性(R2=0.13,p=0.10);更严重TBI未见更大差值(p=0.29)。作者认为比既往推荐更低的ETCO2目标可能安全且合适,院前PaCO2测定可能有用。
要点
- 重型TBI院前急救麻醉后到达医院时,ETCO2-PaCO2差平均1.7(±1.0)kPa(12.8 mm Hg),远大于现行指南假设的0.5 kPa(3.8 mm Hg)。
- ETCO2与PaCO2仅中等相关(R2=0.23,p=0.002),Bland-Altman一致性界限上限3.6 kPa、下限-0.2 kPa,单用ETCO2估计PaCO2不可靠。
- 合并严重胸部创伤者差值更大,为2.0(±1.1)kPa(15.1 mm Hg),p=0.01,且该亚组ETCO2与PaCO2无显著相关(R2=0.13,p=0.10)。
- 更严重TBI未见更大差值(p=0.29);院前采集动脉血者到达医院PaCO2为4.7(±0.2)kPa(35.1 mm Hg)。
- 作者认为比既往推荐更低的ETCO2目标可能安全且合适,院前PaCO2测定可能有用。
适用人群与场景
- 英国东部院前重症团队2015年4月1日至2017年12月31日期间接受院前急诊麻醉(PHEA)的成人重型创伤性脑损伤(TBI)患者。
- 107例符合纳入标准,其中67例在到达医院30 min内未采集PaCO2样本而被排除,最终40例有完整数据按方案纳入分析。
研究设计与关键结果
- 回顾性队列研究,最终纳入40例重型TBI且接受PHEA的成人患者,主要终点为到达医院时ETCO2-PaCO2差。
- 平均ETCO2-PaCO2差为1.7(±1.0)kPa(12.8 mm Hg),ETCO2与PaCO2中等相关(R2=0.23,p=0.002)。
- Bland-Altman偏倚1.7(95%CI 1.4~2.0)kPa,一致性界限上限3.6(95%CI 3.0~4.1)kPa、下限-0.2(95%CI -0.8~0.3)kPa。
- 合并严重胸部创伤者差值2.0(±1.1)kPa(15.1 mm Hg),大于无此情况者,p=0.01;该亚组ETCO2与PaCO2无显著相关(R2=0.13,p=0.10)。
- 更严重TBI未见更大差值(p=0.29);院前采集动脉血者到达医院PaCO2为4.7(±0.2)kPa(35.1 mm Hg)。
证据类型、等级与局限
- 证据类型:回顾性观察性队列研究。
对床旁实践的改变
- 作者认为,比既往推荐更低的ETCO2目标可能安全且合适,提示现行以0.5 kPa(3.8 mm Hg)差值假设设定的4.0-4.5 kPa(30.0-33.8 mm Hg)ETCO2目标可能导致PaCO2高于预期。
- 作者认为院前PaCO2测定可能有用;合并严重胸部创伤时ETCO2-PaCO2差更大(2.0±1.1 kPa),单用ETCO2估计PaCO2的可靠性更差。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: In the UK, 20% of patients with severe traumatic brain injury (TBI) receive prehospital emergency anaesthesia (PHEA). Current guidance recommends an end-tidal carbon dioxide (ETCO2) of 4.0-4.5 kPa (30.0-33.8 mm Hg) to achieve a low-normal arterial partial pressure of CO2 (PaCO2), and reduce secondary brain injury. This recommendation assumes a 0.5 kPa (3.8 mm Hg) ETCO2-PaCO2 gradient. However, the gradient in the acute phase of TBI is unknown. The primary aim was to report the ETCO2-PaCO2 gradient of TBI patients at hospital arrival.
METHODS: A retrospective cohort study of adult patients with serious TBI, who received a PHEA by a prehospital critical care team in the East of England between 1 April 2015 and 31 December 2017. Linear regression was performed to test for correlation and reported as R-squared (R2). A Bland-Altman plot was used to test for paired ETCO2 and PaCO2 agreement and reported with 95% CI. ETCO2-PaCO2 gradient data were compared with a two-tailed, unpaired, t-test.
RESULTS: 107 patients were eligible for inclusion. Sixty-seven patients did not receive a PaCO2 sample within 30 min of hospital arrival and were therefore excluded. Forty patients had complete data and were included in the final analysis; per protocol. The mean ETCO2-PaCO2 gradient was 1.7 (±1.0) kPa (12.8 mm Hg), with moderate correlation (R2=0.23, p=0.002). The Bland-Altman bias was 1.7 (95% CI 1.4 to 2.0) kPa with upper and lower limits of agreement of 3.6 (95% CI 3.0 to 4.1) kPa and -0.2 (95% CI -0.8 to 0.3) kPa, respectively. There was no evidence of a larger gradient in more severe TBI (p=0.29). There was no significant gradient correlation in patients with a coexisting serious thoracic injury (R2=0.13, p=0.10), and this cohort had a larger ETCO2-PaCO2 gradient, 2.0 (±1.1) kPa (15.1 mm Hg), p=0.01. Patients who underwent prehospital arterial blood sampling had an arrival PaCO2 of 4.7 (±0.2) kPa (35.1 mm Hg).
CONCLUSION: There is only moderate correlation of ETCO2 and PaCO2 at hospital arrival in patients with serious TBI. The mean ETCO2-PaCO2 gradient was 1.7 (±1.0) kPa (12.8 mm Hg). Lower ETCO2 targets than previously recommended may be safe and appropriate, and there may be a role for prehospital PaCO2 measurement.
参考来源
- Price J, Sandbach DD, Ercole A, et al. End-tidal and arterial carbon dioxide gradient in serious traumatic brain injury after prehospital emergency anaesthesia: a retrospective observational study. Emerg Med J. 2020. PMID: 32928874. doi:10.1136/emermed-2019-209077
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。